Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Gluckman
E
E
Department of Hematology, Hospital Saint Louis, Paris, France.
Devergie
A
A
Lokiec
F
F
D000284:Administration, Oral; D016026:Bone Marrow Transplantation; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D008727:Methotrexate / Q000627:therapeutic use; D013997:Time Factors
D003524:Cyclosporins; D008727:Methotrexate